MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session – RP Digital

Business

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session

June 21, 20251 min0

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

Deutsche Bank downgrades Babcock to “hold” despite strong FY25 results

rpdigitalJune 27, 20250

Pearson School Report 2025: At least 1.9 million students not ready for their next stage of learning

rpdigitalJune 27, 20250